We have announced the winners of the Capturing Cancer Photography Competition, as chosen by the public vote and our expert judging panel, respectively.
Discover details of the cutting-edge science presented at the 2018 NCRI Cancer Conference in this report from our Editor, Jade Parker. Highlights include the TRACERx study, a fluorescent marker that makes glioma cells glow pink and a breast cancer study.
SOLO-1 is the first, double-blind, randomized, prospective Phase III trial to evaluate front-line olaparib maintenance therapy after platinum-based chemotherapy in newly diagnosed advanced ovarian cancer with BRCA mutation.
Find out about Plinabulin, a novel immuno-oncology agent in late-stage clinical trials for the treatment of chemotherapy-induced neutropenia and advanced NSCLC.
Find out insider details of the KEYNOTE-048 study in this exclusive interview with first author of the study, Barbara Burtness.
Find out about T-VEC, which was the first oncolytic virotherapy that was approved by the FDA as well as the CheckMate 141 trial.
In this opinion piece from our Editor, Jade Parker, you can discover the top 5 breast cancer advancements of 2018.
This past week, the Nobel Prizes in Physiology or Medicine was awarded to research scientists James Allison (University of Texas…
This November, the European Cancer Patient Coalition (ECPC) is very excited to be leading the first Personalized Medicine Awareness Month.
In this podcast, Roshaine Wijayatunga, Senior Editor for Oncology at Future Science Group speaks with Barbara Moss, a Patient Ambassador for Europacolon (UK) and Bowel Cancer UK.